Sanofi is stepping up its long-held interest in antibody-drug conjugates (ADCs). Having first teamed up with Immunogen almost 20 years ago, Sanofi has now joined forces with Seagen to jointly fund and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback